Tarr, Ingrid and Hesselson, Stephanie and Iismaa, Siiri E. and Rath, Emma and Monger, Steven and Troup, Michael and Mishra, Ketan and Wong, Claire M.Y. and Hsu, Pei-Chen and Junday, Keerat and Humphreys, David T. and Adlam, David and Webb, Tom R. and Baranowska-Clarke, Anna A. and Hamby, Stephen E. and Carss, Keren J. and Samani, Nilesh J. and Bax, Monique and McGrath-Cadell, Lucy and Kovacic, Jason C. and Dunwoodie, Sally L. and Fatkin, Diane and Muller, David W.M. and Graham, Robert M. and Giannoulatou, Eleni (2022) Exploring the Genetic Architecture of Spontaneous Coronary Artery Dissection Using Whole-Genome Sequencing. Circulation: Genomic and Precision Medicine, 15 (4). ISSN 2574-8300
Full text not available from this repository.Abstract
BACKGROUND: Spontaneous coronary artery dissection (SCAD) is a cause of acute coronary syndrome that predominantly affects women. Its pathophysiology remains unclear but connective tissue disorders (CTD) and other vasculopathies have been observed in many SCAD patients. A genetic component for SCAD is increasingly appreciated, although few genes have been robustly implicated. We sought to clarify the genetic cause of SCAD using targeted and genome-wide methods in a cohort of sporadic cases to identify both common and rare disease-associated variants. METHODS: A cohort of 91 unrelated sporadic SCAD cases was investigated for rare, deleterious variants in genes associated with either SCAD or CTD, while new candidate genes were sought using rare variant collapsing analysis and identification of novel loss-of-function variants in genes intolerant to such variation. Finally, 2 SCAD polygenic risk scores were applied to assess the contribution of common variants. RESULTS: We identified 10 cases with at least one rare, likely disease-causing variant in CTD-associated genes, although only one had a CTD phenotype. No genes were significantly associated with SCAD from genome-wide collapsing analysis, however, enrichment for TGF (transforming growth factor)-beta signaling pathway genes was found with analysis of 24 genes harboring novel loss-of-function variants. Both polygenic risk scores demonstrated that sporadic SCAD cases have a significantly elevated genetic SCAD risk compared with controls. CONCLUSIONS: SCAD shares some genetic overlap with CTD, even in the absence of any major CTD phenotype. Consistent with a complex genetic architecture, SCAD patients also have a higher burden of common variants than controls.
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Repository Administrator |
| Date Deposited: | 01 Mar 2023 01:35 |
| Last Modified: | 01 Mar 2023 01:35 |
| URI: | https://eprints.victorchang.edu.au/id/eprint/1294 |
Actions (login required)
 |
View Item |